Kodiak Sciences Inc (KOD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.59B
Last updated: Nov 17, 2026 at 4:33 PM ET
Kodiak Sciences Inc (KOD) Statistics
Kodiak Sciences (KOD) has a market cap of $6.59B and an enterprise value of $6.50B. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 19.11% from a year earlier.
Total Valuation
Enterprise value is 1.33% below the market cap, as cash exceeds debt.
| Market Cap | $6.59B |
|---|---|
| Enterprise Value | $6.50B |
| Latest price (Nov 17, 2026) | $96.80 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 396.16% over 52 weeks and trades 22.13% above its 50-day average.
| Beta (1Y) | 0.76 |
|---|---|
| 52-Week Change | +396.16% |
| 1-Month Change | +5.97% |
| 3-Month Change | +141.58% |
| 6-Month Change | +181.23% |
| 5-Year Change | -15.30% |
| Total Return (1Y) | +396.16% |
| Total Return (3Y CAGR) | +238.67% |
| Total Return (5Y CAGR) | -0.78% |
| Return vs SPY (1Y) | +392.08% |
| Max Drawdown (1Y) | -36.24% |
| Max Drawdown (3Y) | -81.10% |
| Sharpe Ratio (1Y) | 1.19 |
| Correlation with SPY (1Y) | 0.08 |
| 50-Day Average | $79.26 |
| 200-Day Average | $46.68 |
| 52-Week Range | $19.04 to $112.79 |
| RSI (14 Days) | 51.9 |
| Average Volume (20 Days) | 851.02K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.70x current liabilities, and total debt is 0.07x shareholder equity.
| Current Ratio | 1.70x |
|---|---|
| Quick Ratio | 1.70x |
| Debt / Equity | 0.07x |
Returns and Efficiency
Return on invested capital is -1481.84% and return on equity is -1962.77% over the last 12 months.
| Return on Equity (ROE) | -1962.77% |
|---|---|
| Return on Assets (ROA) | -117.83% |
| Return on Invested Capital (ROIC) | -1481.84% |
| ROE (5Y Average) | -95.63% |
| ROA (5Y Average) | -50.37% |
Scores
KOD has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | $19.80M |
| Operating Income | -$251.17M |
| Pretax Income | -$246.76M |
| Net Income | -$246.76M |
| EBITDA | -$227.41M |
| Reported EPS (TTM) | -$4.08 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 6.00% of the $209.41M in total assets.
| Cash and Equivalents | $88.68M |
|---|---|
| Total Debt | $826.00K |
| Net Cash | $87.85M |
| Net Cash Per Share | $1.40 |
| Working Capital | $38.15M |
| Shareholder Equity | $12.57M |
| Book Value Per Share | $0.20 |
| Total Assets | $209.41M |
| Total Liabilities | $196.84M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $3.32M of capital spending, operating cash flow left -$172.81M of free cash flow.
| Operating Cash Flow | -$169.49M |
|---|---|
| Capital Expenditures | $3.32M |
| Free Cash Flow | -$172.81M |
| FCF Per Share | -$2.75 |
| Depreciation and Amortization | $23.90M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -23.57% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -23.57% |
Dividends and Yields
KOD does not pay a dividend. Its free cash flow yield is -2.84%.
| FCF Yield | -2.84% |
|---|---|
| Buyback Yield | -2.84% |
| Shareholder Yield | -2.84% |
Peer Position
Against 8 similar companies, KOD has the lowest ROIC.
ROICPeer median -63.50%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +25.96%
| ROIC | -1481.84% vs -63.50% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs +25.96% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About KOD
What is KOD's market cap?
Kodiak Sciences has a market cap of $6.59B. Its enterprise value, which adds debt and subtracts cash, is $6.50B.
How many shares of KOD are outstanding?
Kodiak Sciences has 62.96M shares outstanding. The count is up 19.11% from a year earlier.
Does KOD pay a dividend?
No. Kodiak Sciences does not pay a dividend.
How much debt does KOD have?
Kodiak Sciences has $826.00K of total debt and $88.68M of cash and equivalents, a net cash position of $87.85M.
KOD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors